Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadamu Homma

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Oncoimmunology|May 6, 2015
Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancerShigeo Koido, Sadamu Homma, Masato Okamoto, et al.
BMC Cancer|October 18, 2015
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cellsShin Kan, Shigeo Koido, Masato Okamoto, et al.
Oncology Reports|May 16, 2015
Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansineShin Kan, Shigeo Koido, Masato Okamoto, et al.
Oncology Reports|September 24, 2019
High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancerRyoichi Sawada, Yoshinori Arai, Yukiko Sagawa, et al.
Oncoimmunology|September 28, 2013
The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusionsShigeo Koido, Sadamu Homma, Masato Okamoto, et al.
Cancer Immunology, Immunotherapy : CII|March 15, 2014
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cellsShigeo Koido, Masaki Ito, Yukiko Sagawa, et al.
Anticancer Research|September 10, 2014
Immunological assessment of cryotherapy in breast cancer patientsShigeo Koido, Satoki Kinoshita, Takuji Mogami, et al.
In Vivo (Athens, Greece)|December 3, 2013
Photodynamic diagnosis of colitis-associated dysplasia in a mouse model after oral administration of 5-aminolevulinic acidNobuhiko Komoike, Tomohiro Kato, Hiroki Saijo, et al.
Clinical & Developmental Immunology|November 5, 2010
Regulation of tumor immunity by tumor/dendritic cell fusionsShigeo Koido, Sadamu Homma, Eiichi Hara, et al.
Plos One|December 8, 2015
Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft ModelKazuki Takakura, Yuichiro Shibazaki, Hiroyuki Yoneyama, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Oncoimmunology|May 6, 2015
Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancerShigeo Koido, Sadamu Homma, Masato Okamoto, et al.
BMC Cancer|October 18, 2015
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cellsShin Kan, Shigeo Koido, Masato Okamoto, et al.
Oncology Reports|May 16, 2015
Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansineShin Kan, Shigeo Koido, Masato Okamoto, et al.
Oncology Reports|September 24, 2019
High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancerRyoichi Sawada, Yoshinori Arai, Yukiko Sagawa, et al.
Oncoimmunology|September 28, 2013
The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusionsShigeo Koido, Sadamu Homma, Masato Okamoto, et al.
Cancer Immunology, Immunotherapy : CII|March 15, 2014
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cellsShigeo Koido, Masaki Ito, Yukiko Sagawa, et al.
Anticancer Research|September 10, 2014
Immunological assessment of cryotherapy in breast cancer patientsShigeo Koido, Satoki Kinoshita, Takuji Mogami, et al.
In Vivo (Athens, Greece)|December 3, 2013
Photodynamic diagnosis of colitis-associated dysplasia in a mouse model after oral administration of 5-aminolevulinic acidNobuhiko Komoike, Tomohiro Kato, Hiroki Saijo, et al.
Clinical & Developmental Immunology|November 5, 2010
Regulation of tumor immunity by tumor/dendritic cell fusionsShigeo Koido, Sadamu Homma, Eiichi Hara, et al.
Plos One|December 8, 2015
Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft ModelKazuki Takakura, Yuichiro Shibazaki, Hiroyuki Yoneyama, et al.
Pageof 7